Literature DB >> 2143023

DNA octamer element can confer E1A trans-activation, and adenovirus infection results in a stimulation of the DNA-binding activity of OTF-1/NFIII factor.

S P Chellappan1, J R Nevins.   

Abstract

Adenovirus E1A-dependent trans-activation of viral transcription involves the utilization and alteration of multiple sequence-specific transcription factors. Cellular genes are also activated by E1A, one example being the immunoglobulin heavy-chain locus when assayed by transfection into fibroblast cells. We have explored the basis for the E1A-dependent activation of this cellular transcription unit. We demonstrate that the ATTTGCAT ("octamer") element found in the heavy-chain enhancer and promoter is a target for E1A trans-activation since this sequence can confer inducibility to the normally unresponsive simian virus 40 early promoter. In addition, adenovirus infection stimulates the DNA-binding activity of the ubiquitous octamer-specific factor, OTF-1, and we presume that this is the basis for the stimulation of transcription. Although there are no octamer elements in the adenovirus genome that are known to be important for transcription, there are octamer elements in the viral terminal repeat sequences. These elements bind the NFIII factor and are important for the initiation of DNA replication. Since the NFIII factor has been shown to be identical to OTF-1, we suggest that the stimulation of OTF-1/NFIII activity during an adenovirus infection may be important for efficient initiation of adenovirus DNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2143023      PMCID: PMC54432          DOI: 10.1073/pnas.87.15.5878

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  41 in total

1.  Phosphorylation-dependent activation of the adenovirus-inducible E2F transcription factor in a cell-free system.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

2.  The adenovirus-inducible factor E2F stimulates transcription after specific DNA binding.

Authors:  A S Yee; P Raychaudhuri; L Jakoi; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

3.  Adenovirus E1A-mediated negative control of genes activated during F9 differentiation.

Authors:  K S Young; R Weigel; S Hiebert; J R Nevins
Journal:  Mol Cell Biol       Date:  1989-07       Impact factor: 4.272

4.  DNA-binding activity of the adenovirus-induced E4F transcription factor is regulated by phosphorylation.

Authors:  P Raychaudhuri; S Bagchi; J R Nevins
Journal:  Genes Dev       Date:  1989-05       Impact factor: 11.361

5.  A herpesvirus trans-activating protein interacts with transcription factor OTF-1 and other cellular proteins.

Authors:  T Gerster; R G Roeder
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

Review 6.  Mechanisms of viral-mediated trans-activation of transcription.

Authors:  J R Nevins
Journal:  Adv Virus Res       Date:  1989       Impact factor: 9.937

7.  Cell cycle regulation of H2b histone octamer DNA-binding activity in Chinese hamster lung fibroblasts.

Authors:  M Ito; A Sharma; A S Lee; R Maxson
Journal:  Mol Cell Biol       Date:  1989-02       Impact factor: 4.272

8.  Transcription factor OTF-1 is functionally identical to the DNA replication factor NF-III.

Authors:  E A O'Neill; C Fletcher; C R Burrow; N Heintz; R G Roeder; T J Kelly
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

9.  Direct combinatorial interaction between a herpes simplex virus regulatory protein and a cellular octamer-binding factor mediates specific induction of virus immediate-early gene expression.

Authors:  P O'Hare; C R Goding; A Haigh
Journal:  EMBO J       Date:  1988-12-20       Impact factor: 11.598

10.  A family of octamer-specific proteins present during mouse embryogenesis: evidence for germline-specific expression of an Oct factor.

Authors:  H R Schöler; A K Hatzopoulos; R Balling; N Suzuki; P Gruss
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

View more
  7 in total

1.  The adenovirus E1A-regulated transcription factor E4F is generated from the human homolog of nuclear factor phiAP3.

Authors:  E R Fernandes; R J Rooney
Journal:  Mol Cell Biol       Date:  1997-04       Impact factor: 4.272

2.  Rex-1, a gene encoding a transcription factor expressed in the early embryo, is regulated via Oct-3/4 and Oct-6 binding to an octamer site and a novel protein, Rox-1, binding to an adjacent site.

Authors:  E Ben-Shushan; J R Thompson; L J Gudas; Y Bergman
Journal:  Mol Cell Biol       Date:  1998-04       Impact factor: 4.272

3.  A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein.

Authors:  C Labrie; G F Morris; M B Mathews
Journal:  Mol Cell Biol       Date:  1993-03       Impact factor: 4.272

4.  Repression of the human papillomavirus type 18 enhancer by the cellular transcription factor Oct-1.

Authors:  F Hoppe-Seyler; K Butz; H zur Hausen
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

5.  Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif.

Authors:  M P Felli; A Vacca; D Meco; I Screpanti; A R Farina; M Maroder; S Martinotti; E Petrangeli; L Frati; A Gulino
Journal:  Mol Cell Biol       Date:  1991-09       Impact factor: 4.272

6.  The human papillomavirus type 16 E7 protein complements adenovirus type 5 E1A amino-terminus-dependent transactivation of adenovirus type 5 early genes and increases ATF and Oct-1 DNA binding activity.

Authors:  H K Wong; E B Ziff
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

7.  Positive and negative regulation of the composite octamer motif of the interleukin 2 enhancer by AP-1, Oct-2, and retinoic acid receptor.

Authors:  U de Grazia; M P Felli; A Vacca; A R Farina; M Maroder; L Cappabianca; D Meco; M Farina; I Screpanti; L Frati; A Gulino
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.